Ridgewood Investments’s GSK GSK Stock Holding History

Ridgewood Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,700	Closed	-$7.65K	–	396
2025 Q2	$7.65K	Buy	+1,700	New	+$65K	﹤0.01%	548
2025 Q1	–	Sell	-3,500	Closed	-$8.61K	–	706
2024 Q4	$8.61K	Buy	+3,500	New	+$126K	﹤0.01%	513
2022 Q1	–	Sell	-10,000	Closed	-$57K	–	204
2021 Q4	$57K	Hold	10,000	–	–	0.04%	193
2021 Q3	$27K	Hold	10,000	–	–	0.02%	188
2021 Q2	$29K	Buy	+10,000	New	+$480K	0.02%	190

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ridgewood Investments's GSK Position: Q3 2025 in Review

Ridgewood Investments sold out of GSK (GSK) in Q3 2025, closing a stake of 1,362 shares — an estimated $52.3K sold.

Ridgewood Investments first reported a position in GSK in Q1 2017 and held it in 30 quarters. The position peaked at $1.47M in Q4 2021. 896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Ridgewood Investments reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Ridgewood Investments sold 1,362 GSK shares in Q3 2025, an estimated $52.3K.
Ridgewood Investments first reported a position in GSK in Q1 2017 and held it in 30 quarters.
Ridgewood Investments's GSK position peaked at $1.47M in Q4 2021.
896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.